Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor–Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance)

PURPOSE: Primary endocrine therapy for ductal carcinoma in situ (DCIS) as a potential alternative to surgery has been understudied. This trial explored the feasibility of a short-term course of letrozole and sought to determine whether treatment results in measurable radiographic and biologic change...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Clin Oncol
Main Authors: Hwang, E. Shelley, Hyslop, Terry, Hendrix, Laura H., Duong, Stephanie, Bedrosian, Isabelle, Price, Elissa, Caudle, Abigail, Hieken, Tina, Guenther, Joseph, Hudis, Clifford A., Winer, Eric, Lyss, Alan P., Dickson-Witmer, Diana, Hoefer, Richard, Ollila, David W., Hardman, Timothy, Marks, Jeffrey, Chen, Yunn-Yi, Krings, Gregor, Esserman, Laura, Hylton, Nola
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Clinical Oncology 2020
נושאים:
ORIGINAL REPORTS
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7164489/
https://ncbi.nlm.nih.gov/pubmed/32125937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.00510
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים